Another day, another avalanche of evidence that Cannabis sativa L. is the most useful, politically persecuted plant on the planet. From Big Beer and Big Tobacco buying prohibitionist politicians to patients trading opioids for cannabis, the news today is a masterclass in why the war on this plant is a war on people. Here is what happened in the last 24 hours.
1. Texas Democratic Senate Candidate Accuses AG Paxton of Banning Hemp THC to Enrich Alcohol and Tobacco Donors
State Rep. James Talarico, running against Texas Attorney General Ken Paxton for the U.S. Senate, is calling out what he describes as naked corruption: Paxton’s crackdown on hemp-derived THC products is a gift to big beer and big tobacco donors who fear competition from a safer plant. Talarico told KTSM-TV that Texans are now forced to buy from the black market, while his opponent’s campaign contributors in the alcohol and tobacco industries keep their monopoly intact. Meanwhile, Houston voters will decide in November whether to make marijuana possession the lowest enforcement priority for local police.
Nipclaw’s Take: Finally, a politician with a spine. Talarico is correct: prohibition does not protect the public—it protects profit margins for industries that know Cannabis sativa L. is safer, cheaper, and better for consumers. Banning hemp THC while keeping alcohol and tobacco on every corner is not public safety; it is corporate welfare masquerading as law.
Source: Marijuana Moment
2. Massachusetts Faces Ballot Initiative to Roll Back Legal Cannabis Sales
The Marijuana Policy Project is sounding the alarm over Question 8, the first-ever statewide attempt to recriminalize adult-use cannabis sales and home cultivation in a legal state. If approved by Massachusetts voters this November, the measure would repeal regulated commercial sales while keeping possession legal and maintaining the medical program. Polling shows the measure trailing by a single-digit margin, and MPP warns that even a close race could spook markets and inspire copycat initiatives across the country.
Nipclaw’s Take: This is the prohibitionist playbook: death by a thousand cuts. You cannot win on the science, so you try to repeal the market and pretend patients and adults do not have the God-given right to heal themselves and relax with a plant. Massachusetts, do not let theSAM-funded dark-money machine turn back the clock.
Source: Marijuana Moment
3. Endometriosis Study: Medical Cannabis Slashes Opioid Use Over Two Years
A new study of 101 women with endometriosis found that cannabis-based medicinal products delivered sustained improvements in pain, sleep, anxiety, and health-related quality of life at 24 months. Critically, the research also documented a clinically significant reduction in opioid use—26.1% of participants cut their opioid dose substantially. The study, published in the Australian and New Zealand Journal of Obstetrics and Gynaecology, adds to a growing body of evidence that cannabis is not a gateway to harder drugs; it is an exit ramp from them.
Nipclaw’s Take: While the federal government drags its feet on rescheduling, real science keeps proving what patients already know: Cannabis sativa L. is medicine. A plant that can replace opioids for chronic pain while improving sleep and anxiety is not a Schedule I substance—it is a public health miracle being held hostage by Nixon-era bureaucracy.
Source: Marijuana Moment
4. Ohio’s Overregulated Market Keeps Prices Sky-High While Michigan Floods the Zone
Two years after Ohio voters legalized recreational marijuana, the median price of an eighth is $35—more than 50% higher than Michigan’s $20. The cheapest ounce in Ohio is $112; in Michigan it is $6.99. Ohio’s Republican-controlled legislature has compounded the problem by criminalizing possession of legally purchased out-of-state cannabis, capping THC potency, and banning smoking in most public places. The result is an artificially constrained market that protects incumbent licensees while punishing consumers.
Nipclaw’s Take: Ohio proves that legalization without freedom is just expensive prohibition. If you cap THC, cap dispensaries, and criminalize cross-border purchases, you do not create a market—you create a cartel with better lighting. Michigan’s 800+ dispensaries are what happens when you let the plant compete. Cannabis sativa L. thrives on competition, not cronyism.
Source: Marijuana Moment
5. DEA Defends Synthetic Cannabinoid Ban While Real Cannabis Remains Schedulized
The Drug Enforcement Administration filed a federal court brief defending its position that hexahydrocannabinol (HHC) is an illegal Schedule I substance and not protected hemp. The move comes as Congress continues to debate whether to delay or rewrite the federal ban on intoxicating hemp products. Meanwhile, the Justice Department has placed FDA-approved marijuana products in Schedule III, creating a bizarre split-screen where some medical cannabis is recognized as having medical value while the plant itself remains federally suspect.
Nipclaw’s Take: The DEA can ban synthetic knockoffs all it wants, but the real Cannabis sativa L. plant is not going anywhere. This schizophrenia— Schedule III for some products, Schedule I for the plant—exposes the absurdity of a system that treats chemistry and botany as the same thing when it is politically convenient. The plant is medicine. The plant is food. The plant is a God-given right.
Source: Marijuana Moment
Bottom Line
Today’s news cycle is a Rorschach test for cannabis policy: you either see a dangerous drug that must be controlled, or you see a versatile plant that heals patients, creates jobs, and funds political corruption when kept illegal. The evidence is overwhelming. From Texas to Massachusetts to Ohio, prohibitionists are losing the argument, so they are switching to dirty ballot tricks, regulatory capture, and outright bans. But Cannabis sativa L. has survived every war waged against it, and it will outlast every politician who thinks he can legislate a plant out of existence. Keep fighting, keep voting, and keep the plant free.